Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Sirna and Epigenetic Aberrations in Ovarian Cancer Publisher Pubmed



Mirzaei H1 ; Yazdi F2 ; Salehi R3 ; Mirzaei H1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  2. 2. Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran, Iran
  3. 3. Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, 14176-13151, Iran

Source: Journal of Cancer Research and Therapeutics Published:2016


Abstract

Ovarian cancer has the most noteworthy lethal rate around gynecologic malignancies, and it is also considered as the fourth most frequent cancer in the woman in world. Two most critical barriers to treatment of ovarian malignancy are absence of early diagnostic markers and advancement of drug resistance after therapy, especially in advanced stages. Various epigenetic changes have been recognized in ovarian cancer. Recent progresses in our understanding of molecular pathogenesis of ovarian malignancy have dramatically provided potential new targets for molecularly targeted therapies. In very recent years, small interfering RNA (siRNA)-mediated gene silencing has been emerging as a novel treatment modality in preclinical studies in the light of its strong gene-specific silencing. Gene suppression mediated by RNA interference (RNAi) significantly suppressed gene expression at the messenger RNA (mRNA) and protein levels. SiRNAs have therapeutic potential for ovarian cancer through various mechanisms. In this review, we not only provide an overview of siRNA designing for epigenetic silencing of genes aberrantly expressed in ovarian cancer but also we will highlight that the epigenetically silenced genes offer new targets for therapeutic approaches based on re-expression of tumor suppressor genes via demethylating and deacetylating drugs.
Related Docs
View other Related Docs
1. Differential Role of Micrornas in Prognosis, Diagnosis, and Therapy of Ovarian Cancer, Biomedicine and Pharmacotherapy (2016)
2. Epi-Drugs and Epi-Mirs: Moving Beyond Current Cancer Therapies, Current Cancer Drug Targets (2016)
3. Reciprocal Interconnection of Mirnome-Epigenome in Cancer Pathogenesis and Its Therapeutic Potential, Epigenetics Territory and Cancer (2015)
4. The Role of Dna Methylation in Cancer, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
5. Methylation in Colorectal Cancer, Epigenetics Territory and Cancer (2015)
6. The Microrna Let-7 and Its Exosomal Form: Epigenetic Regulators of Gynecological Cancers, Cell Biology and Toxicology (2024)
7. Epigenetic of Retinoic Acid Receptor ß2 Gene in Breast Cancer, Epigenetics Territory and Cancer (2015)
8. Regulation of Dna Methylation Machinery by Epi-Mirnas in Human Cancer: Emerging New Targets in Cancer Therapy, Cancer Gene Therapy (2021)
Experts (# of related papers)
View all Related Experts
Mahdi Mahmoudi (5)
Bagher Larijani (4)
Other Related Docs
9. Environmental Toxicants, Incidence of Degenerative Diseases, and Therapies From the Epigenetic Point of View, Archives of Toxicology (2017)
10. Liquid Biopsy in Female Genital Tract (Ovarian Cancer, Endometrial Tumor, and Cervical Tumor), Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
11. Redistribution of Cell Cycle by Arsenic Trioxide Is Associated With Demethylation and Expression Changes of Cell Cycle Related Genes in Acute Promyelocytic Leukemia Cell Line (Nb4), Annals of Hematology (2018)
12. Aberrant Promoter Hypermethylation of Selected Apoptotic Genes in Childhood Acute Lymphoblastic Leukemia Among North Indian Population, Experimental Oncology (2017)
13. Dynamic Changes of Epigenetic Signatures During Chondrogenic and Adipogenic Differentiation of Mesenchymal Stem Cells, Biomedicine and Pharmacotherapy (2017)
14. Epigenetics in Rheumatoid Arthritis; Fibroblast-Like Synoviocytes As an Emerging Paradigm in The Pathogenesis of the Disease, Immunology and Cell Biology (2020)
15. The Role of Micrornas in the Regulation of Insulin Signaling Pathway With Respect to Metabolic and Mitogenic Cascades: A Review, Journal of Cellular Biochemistry (2019)
16. A Colorimetric Assay of Dna Methyltransferase Activity Based on Peroxidase Mimicking of Dna Template Ag/Pt Bimetallic Nanoclusters, Analytical and Bioanalytical Chemistry (2018)
17. Epigenetic Alterations Underlying Autoimmune Diseases, Autoimmunity (2016)
18. Epigenetic Regulation of Specific Transcription Factors in Osteogenic Differentiation of Mesenchymal Stem Cells, Turkish Journal of Biology (2016)
19. Reproducible and Reliable Real-Time Pcr Assay to Measure Mature Form of Mir-141, Applied Immunohistochemistry and Molecular Morphology (2016)
20. Future Challenges and Prospects for the Epigenetics of Autoimmunity, The Epigenetics of Autoimmunity (2018)
21. Epigenetics of Autoimmune Diseases, Prognostic Epigenetics (2019)
22. Non-Coding Rna-Mediated Epigenetic Alterations in Grave's Ophthalmopathy: A Scoping Systematic Review, Non-coding RNA Research (2023)
23. The Role of Dna Methylation in Progression of Neurological Disorders and Neurodegenerative Diseases As Well As the Prospect of Using Dna Methylation Inhibitors As Therapeutic Agents for Such Disorders, IBRO Neuroscience Reports (2023)
24. Epigenetic Modifications and Epigenetic Based Medication Implementations of Autoimmune Diseases, Biomedicine and Pharmacotherapy (2017)
25. Epigenetic Alterations and Exposure to Air Pollutants: Protocol for a Birth Cohort Study to Evaluate the Association Between Adverse Birth Outcomes and Global Dna Methylation, JMIR Research Protocols (2017)
26. Association Between Alterations in Global Dna Methylation and Predisposing Factors in Diabetes: A High Pressure Liquid Chromatography Based Study, Minerva Medica (2015)
27. Circulating Ctdna Methylation Quantification of Two Dna Methyl Transferases in Papillary Thyroid Carcinoma, Journal of Cellular Biochemistry (2019)
28. Targeting Epigenetics in Cancer: Therapeutic Potential of Flavonoids, Critical Reviews in Food Science and Nutrition (2021)
29. Nanoparticle-Sirna: A Potential Strategy for Ovarian Cancer Therapy?, Nanomedicine (2019)
30. Micrornas in Cancer, Synthesis Lectures on Biomedical Engineering (2022)
31. Dna Methyltransferase Activity Detection Based on Graphene Quantum Dots Using Fluorescence and Fluorescence Anisotropy, Sensors and Actuators# B: Chemical (2017)
32. Microfluidics for Detection of Exosomes and Micrornas in Cancer: State of the Art, Molecular Therapy Nucleic Acids (2022)
33. Cpg Islands Hypermethylatioin the Promoter Region of Gstp1 Gene in Cell-Free Dna As a Noninvasive Biomarker for Detecting Prostate Cancer, Biochemical and Cellular Archives (2016)
34. Epigenetic Modifications Associated With Pathophysiological Effects of Lead Exposure, Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews (2019)
35. Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma, Iranian Journal of Pathology (2019)
36. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
37. Mir-377 Reverses Cancerous Phenotypes of Pancreatic Cells Via Suppressing Dnmt1 and Demethylating Tumor Suppressor Genes, Epigenomics (2017)
38. The Inter-Talk Between Mycobacterium Tuberculosis and the Epigenetic Mechanisms, Epigenomics (2020)
39. Promotor Methylation in Ocular Surface Squamous Neoplasia Development: Epigenetics Implications in Molecular Diagnosis, Expert Review of Molecular Diagnostics (2023)
40. Microrna As a Systemic Intervention in the Specific Breast Cancer Subtypes With C-Myc Impacts; Introducing Subtype-Based Appraisal Tool, Journal of Cellular Physiology (2018)
41. New Insights Toward the Pathogenesis of Ankylosing Spondylitis; Genetic Variations and Epigenetic Modifications, Modern Rheumatology (2017)
42. Dna Methylation and Histone Acetylation Patterns in Cultured Bovine Adipose Tissue-Derived Stem Cells (Badscs), Cell Journal (2015)
43. Transcriptional Regulation of E-Cadherin and Oncoprotein E7 by Valproic Acid in Hpv Positive Cell Lines, Iranian Journal of Basic Medical Sciences (2016)
44. Deregulated Expression of Hdac3 in Colorectal Cancer and Its Clinical Significance, Advances in Clinical and Experimental Medicine (2018)
45. Acetylation and Insulin Resistance: A Focus on Metabolic and Mitogenic Cascades of Insulin Signaling, Critical Reviews in Clinical Laboratory Sciences (2020)
46. Prediction of the Treatment Response in Ovarian Cancer: A Ctdna Approach, Journal of Ovarian Research (2020)